Get startedLog in
    Picture of Kezar Life Sciences logo

    KZR — Kezar Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: Aurinia Pharmaceuticals To Acquire Kezar Life Sciences For $6.955 In Cash Per Share Plus A Contingent Value Right

    Picture of Kezar Life Sciences logoKezar Life Sciences
    30/03/2026 14:59
    March 30 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O:

AURINIA PHARMACEUTICALS TO ACQUIRE KEZAR LIFE SCIENCES FOR $6.955 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

AURINIA PHARMACEUTICALS TO ACQUIRE KEZAR LIFE SCIENCES FOR $6.955 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

AURINIA PHARMACEUTICALS INC - CVR INCLUDES PAYMENTS FROM ZETOMIPZOMIB, EVEREST, ENODIA, AND NET CASH OVER $50 MILLION

Source text: ID:nBwLVLvLa

Further company coverage: AUPH.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kezar Life Sciences

    See all news